Individualized ANH for Non-cardiac Surgery

Condition(s) studied

Investigational drug(s) / intervention(s)

Individualized ANH: Participants will undergo individualized ANH based on the West China Liu's Score after anesthetic induction. The decision of autologous blood transfusion or allogeneic red cell transfusion will be made according to the West China Liu's Score.

Study summary

In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.

Eligibility

Primary outcome measure(s)

• ABT requirement — Up to 12 weeks.
  The perioperative allogeneic red blood cells consumption (Units per person).

Trial sites (1)

More West China Hospital trials in China